Please wait while your page loads ...
From Thursday, September 24, 2020 until Friday, September 25, 2020
The FARA 2020 Biomarker & Clinical Endpoint Meeting will be held virtually on September 24th and 25th, 2020.
The purpose of the meeting will be to review the state of biomarker and novel endpoint development for Friedreich's ataxia. The focus will be on pharmacodynamic and monitoring biomarkers both for translational and clinical applications, as well as clinical outcome assessments. FARA’s goal is to have a toolbox of biomarkers and outcome assessments that can be used in various settings and for diverse treatment approaches. Highly innovative biomarkers or outcome assessments at early stages of development will be considered, as well as research in later or validation stages.
The meeting agenda can be viewed here
Meeting registration is free of charge.